Diabetes mellitus and prostate cancer metabolism: Is there a relationship?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/107500 https://doi.org/10.4081/aiua.2018.3.184 |
Resumo: | Objective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness. |
id |
RCAP_89893d5e6107ba53517acd02ce11ef1e |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/107500 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship?DiabetesGlucoseProstate cancerHormonal receptors18F-FDG.AgedBlood GlucoseCell Line, TumorCell ProliferationCross-Sectional StudiesDiabetes MellitusFlow CytometryHumansMaleMiddle AgedPC-3 CellsProstatectomyProstatic NeoplasmsReceptor, ErbB-2Receptors, AndrogenObjective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness.Istituto di Urologia2018-09-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107500http://hdl.handle.net/10316/107500https://doi.org/10.4081/aiua.2018.3.184eng1124-3562Antunes, Hugo PontesTeixo, RicardoCarvalho, João AndréEliseu, MiguelMarques, InêsMamede, AnaNeves, RitaOliveira, RuiSilva, Edgar Tavares daParada, BelmiroAbrantes, Ana M.Figueiredo, ArnaldoBotelho, Maria Filomenainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-17T10:04:51Zoai:estudogeral.uc.pt:10316/107500Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:50.881765Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
title |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
spellingShingle |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? Antunes, Hugo Pontes Diabetes Glucose Prostate cancer Hormonal receptors 18F-FDG. Aged Blood Glucose Cell Line, Tumor Cell Proliferation Cross-Sectional Studies Diabetes Mellitus Flow Cytometry Humans Male Middle Aged PC-3 Cells Prostatectomy Prostatic Neoplasms Receptor, ErbB-2 Receptors, Androgen |
title_short |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
title_full |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
title_fullStr |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
title_full_unstemmed |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
title_sort |
Diabetes mellitus and prostate cancer metabolism: Is there a relationship? |
author |
Antunes, Hugo Pontes |
author_facet |
Antunes, Hugo Pontes Teixo, Ricardo Carvalho, João André Eliseu, Miguel Marques, Inês Mamede, Ana Neves, Rita Oliveira, Rui Silva, Edgar Tavares da Parada, Belmiro Abrantes, Ana M. Figueiredo, Arnaldo Botelho, Maria Filomena |
author_role |
author |
author2 |
Teixo, Ricardo Carvalho, João André Eliseu, Miguel Marques, Inês Mamede, Ana Neves, Rita Oliveira, Rui Silva, Edgar Tavares da Parada, Belmiro Abrantes, Ana M. Figueiredo, Arnaldo Botelho, Maria Filomena |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Antunes, Hugo Pontes Teixo, Ricardo Carvalho, João André Eliseu, Miguel Marques, Inês Mamede, Ana Neves, Rita Oliveira, Rui Silva, Edgar Tavares da Parada, Belmiro Abrantes, Ana M. Figueiredo, Arnaldo Botelho, Maria Filomena |
dc.subject.por.fl_str_mv |
Diabetes Glucose Prostate cancer Hormonal receptors 18F-FDG. Aged Blood Glucose Cell Line, Tumor Cell Proliferation Cross-Sectional Studies Diabetes Mellitus Flow Cytometry Humans Male Middle Aged PC-3 Cells Prostatectomy Prostatic Neoplasms Receptor, ErbB-2 Receptors, Androgen |
topic |
Diabetes Glucose Prostate cancer Hormonal receptors 18F-FDG. Aged Blood Glucose Cell Line, Tumor Cell Proliferation Cross-Sectional Studies Diabetes Mellitus Flow Cytometry Humans Male Middle Aged PC-3 Cells Prostatectomy Prostatic Neoplasms Receptor, ErbB-2 Receptors, Androgen |
description |
Objective: Our aim was to evaluate the effects of glucose levels and diabetes mellitus in prostate cancer (PCa) biology. Materials and methods: Two PCa cell lines (LNCap and PC3) were cultured in RPMI medium with different glucose concentrations [5mM (LG) and 25mM (HG)]. Expressions of androgen receptor, Her2/neu and glucose transporters (GLUT1, 3, 5 and 12) were evaluated by flow cytometry. Proliferation rate was assessed by colorimetric assay MTT and cellular characterization was performed by haematoxylin and eosin staining. Additionally, we performed a cross sectional analysis of 704 patients undergoing radical prostatectomy who were divided into two groups (diabetic and non-diabetic). An analysis of clinical and histological data seeking to identify the differences on tumor aggressiveness between the two groups was performed. Results: In LNCaP cell line, when the glucose concentration in the medium increased, there was an increased in AR expression. Regarding expression of Her2/neu receptor, medium’s glucose concentration significantly changed the expression of this receptor in both PC3 and LNCaP cell lines. Growth rate was higher on the HG medium for both cell lines. The clinical study of patients undergoing radical prostatectomy revealed no relationship between the presence of diabetes and the development of more aggressive tumours. Diabetic patients had significantly higher prostatic volumes, however, no significant difference was found between the relapse risk classification or the ISUP classification between the two groups. Conclusions: Our results showed that medium glucose concentration could influence prostate cancer cells growing but not the aggressiveness. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-09-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/107500 http://hdl.handle.net/10316/107500 https://doi.org/10.4081/aiua.2018.3.184 |
url |
http://hdl.handle.net/10316/107500 https://doi.org/10.4081/aiua.2018.3.184 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1124-3562 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Istituto di Urologia |
publisher.none.fl_str_mv |
Istituto di Urologia |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134124519194625 |